Recent research has found that Iberverin can simultaneously downregulate the expression levels of SLC7A11 mRNA and GPX4, thereby inducing lipid peroxidation and ferroptosis, effectively suppressing the proliferation of HCC cells. Here, GPX4 is linked to hepatocellular carcinoma.